Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
07 2022
Historique:
received: 02 08 2021
revised: 28 01 2022
accepted: 15 02 2022
pubmed: 25 2 2022
medline: 28 6 2022
entrez: 24 2 2022
Statut: ppublish

Résumé

To develop and validate a deep learning (DL) system for predicting each point on visual fields (VFs) from disc and OCT imaging and derive a structure-function mapping. Retrospective, cross-sectional database study. A total of 6437 patients undergoing routine care for glaucoma in 3 clinical sites in the United Kingdom. OCT and infrared reflectance (IR) optic disc imaging were paired with the closest VF within 7 days. EfficientNet B2 was used to train 2 single-modality DL models to predict each of the 52 sensitivity points on the 24-2 VF pattern. A policy DL model was designed and trained to fuse the 2 model predictions. Pointwise mean absolute error (PMAE). A total of 5078 imaging scans to VF pairs were used as a held-out test set to measure the final performance. The improvement in PMAE with the policy model was 0.485 (0.438, 0.533) decibels (dB) compared with the IR image of the disc alone and 0.060 (0.047, 0.073) dB with to the OCT alone. The improvement with the policy fusion model was statistically significant (P < 0.0001). Occlusion masking shows that the DL models learned the correct structure-function mapping in a data-driven, feature agnostic fashion. The multimodal, policy DL model performed the best; it provided explainable maps of its confidence in fusing data from single modalities and provides a pathway for probing the structure-function relationship in glaucoma.

Identifiants

pubmed: 35202616
pii: S0161-6420(22)00156-7
doi: 10.1016/j.ophtha.2022.02.017
pmc: PMC9233104
mid: NIHMS1799573
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

781-791

Subventions

Organisme : NEI NIH HHS
ID : K23 EY029246
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG066567
Pays : United States

Informations de copyright

Copyright © 2022 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Références

PLoS One. 2020 Jul 6;15(7):e0234902
pubmed: 32628672
Transl Vis Sci Technol. 2020 Sep 14;9(10):15
pubmed: 32974087
Transl Vis Sci Technol. 2021 Jun 1;10(7):4
pubmed: 34086043
Ophthalmology. 1982 Mar;89(3):268-79
pubmed: 7088510
Ophthalmology. 2000 Oct;107(10):1809-15
pubmed: 11013178
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3249-56
pubmed: 19324839
Ophthalmol Glaucoma. 2021 Jan-Feb;4(1):102-112
pubmed: 32826205
Invest Ophthalmol Vis Sci. 2012 Oct 09;53(11):6981-90
pubmed: 22969077
J Vis. 2013 Mar 14;13(4):
pubmed: 23492926
Sci Rep. 2020 Dec 3;10(1):21052
pubmed: 33273643
J Glaucoma. 2020 Mar;29(3):191-197
pubmed: 32108691
Transl Vis Sci Technol. 2021 Jan 08;10(1):19
pubmed: 33510958
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6320-5
pubmed: 26436884
Transl Vis Sci Technol. 2020 Mar 30;9(2):19
pubmed: 32818080
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2201-4
pubmed: 10892863
Transl Vis Sci Technol. 2018 Dec 28;7(6):36
pubmed: 30619656
Vision Res. 2007 Oct;47(22):2901-11
pubmed: 17320143
Br J Ophthalmol. 2014 Jul;98 Suppl 2:ii15-9
pubmed: 24357497
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2654-9
pubmed: 12147599
Invest Ophthalmol Vis Sci. 2013 Sep 09;54(9):6074-82
pubmed: 23882689
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3975-3985
pubmed: 28796875
Optom Vis Sci. 2015 Jan;92(1):70-82
pubmed: 25415282
Transl Vis Sci Technol. 2013 May;2(4):3
pubmed: 24049720
Graefes Arch Clin Exp Ophthalmol. 1992;230(2):111-4
pubmed: 1577288
Ophthalmology. 2020 Mar;127(3):346-356
pubmed: 31718841
Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2424-30
pubmed: 22427540
Vision Res. 2009 Aug;49(17):2157-63
pubmed: 19539641
Ophthalmol Glaucoma. 2020 May - Jun;3(3):210-217
pubmed: 32672618
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Br J Ophthalmol. 1998 Apr;82(4):352-61
pubmed: 9640180
Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2760-9
pubmed: 22467579
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5657-66
pubmed: 20505207
Ophthalmology. 2017 Nov;124(11):1612-1620
pubmed: 28676280
Br J Ophthalmol. 2021 Apr;105(4):507-513
pubmed: 32593978
Exp Eye Res. 2012 Dec;105:70-8
pubmed: 23099334
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4787-95
pubmed: 14578400
Prog Retin Eye Res. 2007 Nov;26(6):688-710
pubmed: 17889587
Sci Rep. 2021 Jun 15;11(1):12562
pubmed: 34131181
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6208-16
pubmed: 26426403

Auteurs

Yuka Kihara (Y)

University of Washington, Department of Ophthalmology, Seattle, Washington.

Giovanni Montesano (G)

City, University of London, Optometry and Visual Sciences, London, United Kingdom; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, UK.

Andrew Chen (A)

University of Washington, Department of Ophthalmology, Seattle, Washington.

Nishani Amerasinghe (N)

University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Chrysostomos Dimitriou (C)

Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Colchester, United Kingdom.

Aby Jacob (A)

University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Almira Chabi (A)

Santen, Emeryville, California.

David P Crabb (DP)

City, University of London, Optometry and Visual Sciences, London, United Kingdom.

Aaron Y Lee (AY)

University of Washington, Department of Ophthalmology, Seattle, Washington. Electronic address: aaronylee@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH